You are here: Home » Reuters » News
Business Standard

Takeda shareholder group aims to block $62 billion Shire deal

Reuters  |  TOKYO 

By Sam NusseyTOKYO (Reuters) - A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday.Takeda will hold the shareholder meeting later this year or early next year to approve an issue of new stock to help fund the Shire deal, making it a de facto vote on the deal itself.The 130 member group formed by ex-Takeda employees holds one percent of the drugmaker's shares, and needs to secure a third of shareholder votes.It is ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, June 11 2018. 17:35 IST